Menopausal stage linked to diabetes drug benefits in women
An observational analysis of 152,617 women aged 40–65 linked earlier menopausal stages to greater benefits from one class of diabetes and weight-loss drugs.
Our read
Interventions- Studied:
- Cohort study of 152,617 midlife women with diabetes or obesity, 12 months
- What changed:
- Cardiometabolic benefits were greatest in premenopausal women and attenuated progressively with advancing menopausal stage
- The catch:
- Differences in health or care between women may have contributed to the patterns
- Why it’s aging research:
- It studies an intervention with evidence of extending healthy life.
Editor of record: Boris Djordjevic · AgingResearch.News
Women aged 40–65 with type 2 diabetes and/or overweight or obesity made up the 152,617 participants in an observational analysis of All of Us Research Program electronic health records. It included 5,837 women starting GLP-1 receptor agonists, a class of diabetes and weight-loss drugs, and 144,896 untreated women. Researchers assessed changes at 3, 6 and 12 months across five menopausal stages.
At 12 months, GLP-1 receptor agonist use was associated with reductions of 4.86 kilograms in body weight and 0.61 percentage points in HbA1c, a measure of average blood sugar, compared with untreated women. The linked benefits were greatest before menopause and early in the menopause transition, and weakened progressively at later stages. Menopausal stage modified associations with blood sugar at all three follow-up points.
Why it matters
The findings bear on whether care for diabetes and excess weight should account for reproductive aging. The authors supported prescribing informed by menopausal stage and called for trials that compare results across these stages.
Caveats
Women were not randomly assigned drugs, so differences in their health or care may have contributed to the patterns. The findings concern women aged 40–65 with diabetes and/or overweight or obesity, not all women going through menopause.
The paper
Johns Hopkins Sch of Nursing
AHA Scientific Sessions 2026 Abstract, Nov 2, 2026
Presented at AHA Scientific Sessions 2026, abstract 11425
Comments
Be the first to comment.